Lack of association between prior infection with chlamydia pneumoniaeand acute or chronic coronary artery disease
Open Access
- 3 February 1999
- journal article
- research article
- Published by Wiley in Clinical Cardiology
- Vol. 22 (2) , 85-90
- https://doi.org/10.1002/clc.4960220206
Abstract
Hypothesis: The study was designed to establish a lack of relationship between chronic C. pneumoniae infection and CHD. Methods: Chlamydia-specific IgG-antibody was assayed using an indirect immunofluorescence test in the serum of 159 patients with severe arterial disease and 203 patients with a heart valve prostheses and no demonstrable CHD. Fatal and nonfatal vascular events and systemic thromboembolism were recorded over a 2-year period. Results: In the arterial group 107 patients (67.3%) and in the valvular group 120/203 (59.1%) were positive for C. pneumoniae antibody. The number of patients with fatal or nonfatal vascular events (double end point) in the arterial and valvular groups was 23 and 2, respectively (p<.0001). Triple end points (fatal plus nonfatal vascular events plus thromboembolism) were also more frequent in the arterial group (p< 0.002). The prevalence of chlamydia antibody positivity was the same in the arterial and valvular groups, and the occurrence of clinical events was also the same for chlamydia-positive (227 patients) as for chlamydia-negative (135 patients). After adjustment for confounding variables, only arterial disease was a predictive factor for double (OR 17.0; 95% CI 3.94–73.3) or triple (OR 3.12; 95% CI 1.56–6.25) end points. Conclusion: We find C. pneumoniae chronic infection not to be an independent risk factor for acute or chronic arterial disease.Keywords
This publication has 20 references indexed in Scilit:
- Interactive Role of Infection, Inflammation and Traditional Risk Factors in Atherosclerosis and Coronary Artery Disease 11This study was supported in part by a Merit Review grant from the Department of Veterans Affairs Central Office, Washington, D.C.Journal of the American College of Cardiology, 1998
- Roles of Infectious Agents in Atherosclerosis and RestenosisCirculation, 1997
- Comparison of High-Dose With Low-Dose Aspirin in Patients With Mechanical Heart Valve Replacement Treated With Oral AnticoagulantCirculation, 1996
- Increased incidence of Chlamydiaspecies within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular diseaseJournal of the American College of Cardiology, 1996
- Chlamydia pneumoniae (TWAR) in Atherosclerosis of the Carotid ArteryCirculation, 1995
- Fibrinogen: a link between chronic infection and coronary heart diseaseThe Lancet, 1994
- Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease.Circulation, 1993
- Myocarditis caused by Chlamydia pneumoniae (TWAR) and sudden unexpected death in a Swedish elite orienteerThe Lancet, 1992
- Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988